Identification Generic Name (2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid DrugBank Accession Number DB02625 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid (DB02625) ×  Close Weight Average: 189.209  Monoisotopic: 189.100107973  Chemical Formula C 8 H 15 NO 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Formylmethionine deformylase, putative Not Available Plasmodium falciparum (isolate 3D7) Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as medium-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Kingdom Organic compounds Super Class Lipids and lipid-like molecules Class Fatty Acyls Sub Class Fatty acids and conjugates Direct Parent Medium-chain fatty acids Alternative Parents Branched fatty acids  /  Amino fatty acids  /  Hydroxamic acids  /  Monocarboxylic acids and derivatives  /  Carboxylic acids  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds Substituents Aliphatic acyclic compound  /  Amino fatty acid  /  Branched fatty acid  /  Carbonyl group  /  Carboxylic acid  /  Carboxylic acid derivative  /  Hydrocarbon derivative  /  Hydroxamic acid  /  Medium-chain fatty acid  /  Monocarboxylic acid or derivatives Molecular Framework Aliphatic acyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key NOSUUIPGNMAALM-SSDOTTSWSA-N InChI InChI=1S/C8H15NO4/c1-2-3-4-7(8(11)12)5-9(13)6-10/h6-7,13H,2-5H2,1H3,(H,11,12)/t7-/m1/s1 IUPAC Name (2R)-2-[(N-hydroxyformamido)methyl]hexanoic acid SMILES [H][C@@](CCCC)(CN(O)C=O)C(O)=O References General References Not Available External Links PubChem Compound 5287843 PubChem Substance 46504579 ChemSpider 4450133 ZINC ZINC000012502376 PDBe Ligand BRR PDB Entries 1rl4 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 16.4 mg/mL ALOGPS logP 0.38 ALOGPS logP 0.73 Chemaxon logS -1.1 ALOGPS pKa (Strongest Acidic) 4.4 Chemaxon pKa (Strongest Basic) -5.7 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 77.84 Å 2 Chemaxon Rotatable Bond Count 6 Chemaxon Refractivity 45.8 m 3 ·mol -1 Chemaxon Polarizability 19.28 Å 3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.8279 Blood Brain Barrier + 0.851 Caco-2 permeable - 0.6405 P-glycoprotein substrate Non-substrate 0.6451 P-glycoprotein inhibitor I Non-inhibitor 0.8949 P-glycoprotein inhibitor II Non-inhibitor 0.9549 Renal organic cation transporter Non-inhibitor 0.9536 CYP450 2C9 substrate Non-substrate 0.8111 CYP450 2D6 substrate Non-substrate 0.8149 CYP450 3A4 substrate Non-substrate 0.609 CYP450 1A2 substrate Non-inhibitor 0.8125 CYP450 2C9 inhibitor Non-inhibitor 0.8271 CYP450 2D6 inhibitor Non-inhibitor 0.9115 CYP450 2C19 inhibitor Non-inhibitor 0.8272 CYP450 3A4 inhibitor Non-inhibitor 0.8647 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9685 Ames test Non AMES toxic 0.6164 Carcinogenicity Non-carcinogens 0.6491 Biodegradation Not ready biodegradable 0.7023 Rat acute toxicity 2.0101 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9723 hERG inhibition (predictor II) Non-inhibitor 0.849    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Formylmethionine deformylase, putative Kind Protein Organism Plasmodium falciparum (isolate 3D7) Pharmacological action Unknown General Function Peptide deformylase activity Specific Function Removes the formyl group from the N-terminal Met of newly synthesized proteins. Gene Name Not Available Uniprot ID Q8I372 Uniprot Name Peptide deformylase Molecular Weight 28393.87 Da × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at August 01, 2020 13:44 